- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 485103, 8 pages
From the Mediterranean to the Sea of Japan: The Transcontinental Odyssey of Autoinflammatory Diseases
1Institute of Pediatrics, Università Cattolica Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
2Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
Received 14 May 2013; Revised 23 June 2013; Accepted 25 June 2013
Academic Editor: Ruben Queiro-Silva
Copyright © 2013 Donato Rigante et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. J. Hashkes and O. Toker, “Autoinflammatory syndromes,” Pediatric Clinics of North America, vol. 59, no. 2, pp. 447–470, 2012.
- M. Lamkanfi and V. M. Dixit, “Inflammasomes and their roles in health and disease,” Annual Review of Cell and Developmental Biology, vol. 28, pp. 137–161, 2012.
- D. Rigante, “The fresco of autoinflammatory diseases from the pediatric perspective,” Autoimmunity Reviews, vol. 11, no. 5, pp. 348–356, 2012.
- E. Ben-Chetrit and I. Touitou, “Familial Mediterranean fever in the world,” Arthritis Care and Research, vol. 61, no. 10, pp. 1447–1453, 2009.
- G. Guz, M. Kanbay, and M. A. Ozturk, “Current perspectives on familial Mediterranean fever,” Current Opinion in Infectious Diseases, vol. 22, no. 3, pp. 309–315, 2009.
- E. Ben-Chetrit and M. Levy, “Familial Mediterranean fever,” The Lancet, vol. 351, no. 9103, pp. 659–664, 1998.
- D. Rigante, I. La Torraca, V. Ansuini, A. Compagnone, A. Sallì, and A. Stabile, “The multi-face expression of familial Mediterranean fever in the child,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 4, pp. 163–171, 2006.
- D. Cattan, “Familial Mediterranean fever: is low mortality from tuberculosis a specific advantage for MEFV mutations carriers? Mortality from tuberculosis among Muslims, Jewish, French, Italian and Maltese patients in Tunis (Tunisia) in the first half of the 20th century,” Clinical and Experimental Rheumatology, vol. 21, supplement 30, pp. S53–S54, 2003.
- V. P. Papadopoulos, S. Giaglis, I. Mitroulis, and K. Ritis, “The population genetics of familial Mediterranean fever: a meta-analysis study,” Annals of Human Genetics, vol. 72, part 6, pp. 752–761, 2008.
- N. Jalkh, E. Génin, E. Chouery et al., “Familial Mediterranean fever in Lebanon: founder effects for different MEFV mutations,” Annals of Human Genetics, vol. 72, no. 1, pp. 41–47, 2008.
- A. Tsuchiya-Suzuki, M. Yazaki, A. Nakamura et al., “Clinical and genetic features of familial Mediterranean fever in Japan,” Journal of Rheumatology, vol. 36, no. 8, pp. 1671–1676, 2009.
- D. Ebrahimi-Fakhari, S. O. Schِnland, U. Hegenbart et al., “Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk,” Scandinavian Journal of Rheumatology, vol. 42, no. 1, pp. 52–58, 2013.
- I. Touitou, T. Sarkisian, M. Medlej-Hashim et al., “Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever,” Arthritis and Rheumatism, vol. 56, no. 5, pp. 1706–1712, 2007.
- E. Sohar, J. Gafni, M. Pras, and H. Heller, “Familial Mediterranean fever. A survey of 470 cases and review of the literature,” The American Journal of Medicine, vol. 43, no. 2, pp. 227–253, 1967.
- J. Samuels, I. Aksentijevich, Y. Torosyan et al., “Familial Mediterranean fever at the millennium clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health,” Medicine, vol. 77, no. 4, pp. 268–297, 1998.
- A. Livneh, P. Langevitz, D. Zemer et al., “Criteria for the diagnosis of familial Mediterranean fever,” Arthritis and Rheumatism, vol. 40, no. 10, pp. 1879–1885, 1997.
- A. Soriano and R. Manna, “Familial Mediterranean fever: new phenotypes,” Autoimmunity Reviews, vol. 12, no. 1, pp. 31–37, 2012.
- D. Rigante, I. La Torraca, L. Avallone, A. L. Pugliese, S. Gaspari, and A. Stabile, “The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 4, pp. 173–178, 2006.
- R. Roldan, A. M. Ruiz, M. D. Miranda, and E. Collantes, “Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine,” Joint Bone Spine, vol. 75, no. 4, pp. 504–505, 2008.
- J. W. M. van der Meer, J. M. Vossen, J. Radl et al., “Hyperimmunoglobulinemia D and periodic fever: a new syndrome,” The Lancet, vol. 1, no. 8386, pp. 1087–1090, 1984.
- H. J. Lachmann, “Clinical immunology review series: an approach to the patient with a periodic fever syndrome,” Clinical and Experimental Immunology, vol. 165, no. 3, pp. 301–309, 2011.
- J. Vuch, A. Marcuzzi, A. M. Bianco, A. Tommasini, V. Zanin, and S. Crovella, “Evolutionary hypothesis of the mevalonate kinase deficiency,” Medical Hypotheses, vol. 80, no. 1, pp. 67–69, 2013.
- J. P. H. Drenth, C. J. Haagsma, J. W. M. van der Meer et al., “Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients,” Medicine, vol. 73, no. 3, pp. 133–144, 1994.
- W. Ammouri, L. Cuisset, S. Rouaghe et al., “Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome,” Rheumatology, vol. 46, no. 10, pp. 1597–1600, 2007.
- D. Rigante, V. Ansuini, B. Bertoni et al., “Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome,” Rheumatology International, vol. 27, no. 1, pp. 97–100, 2006.
- E. J. Bodar, L. M. Kuijk, J. P. H. Drenth, J. W. M. van der Meer, A. Simon, and J. Frenkel, “On-demand anakinra treatment is effective in mevalonate kinase deficiency,” Annals of the Rheumatic Diseases, vol. 70, no. 12, pp. 2155–2158, 2011.
- J. P. H. Drenth, M. van Deuren, J. van der Ven-Jongekrijg, C. G. Schalkwijk, and J. W. M. van der Meer, “Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome,” Blood, vol. 85, no. 12, pp. 3586–3593, 1995.
- I. Aksentijevich, J. Galon, M. Soares et al., “The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers,” The American Journal of Human Genetics, vol. 69, no. 2, pp. 301–314, 2001.
- B. Nedjai, G. A. Hitman, L. D. Church et al., “Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients,” Cellular Immunology, vol. 268, no. 2, pp. 55–59, 2011.
- J. G. Ryan and R. Goldbach-Mansky, “The spectrum of autoinflammatory diseases: recent bench to bedside observations,” Current Opinion in Rheumatology, vol. 20, no. 1, pp. 66–75, 2008.
- S. Stojanov and M. F. McDermott, “The tumour necrosis factor receptor-associated periodic syndrome: current concepts,” Expert Reviews in Molecular Medicine, vol. 7, no. 22, pp. 1–18, 2005.
- A. Dinc, H. Erdem, D. Rowczenio et al., “Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family,” Journal of Nephrology, vol. 18, no. 5, pp. 626–629, 2005.
- L. Cantarini, D. Rigante, O. M. Lucherini et al., “Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 3, pp. 701–707, 2010.
- M. Gattorno, M. A. Pelagatti, A. Meini et al., “Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome,” Arthritis and Rheumatism, vol. 58, no. 5, pp. 1516–1520, 2008.
- L. Cantarini, O. M. Lucherini, B. Frediani et al., “Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes,” International Journal of Immunopathology and Pharmacology, vol. 24, no. 4, pp. 827–836, 2011.
- L. Maksimovic, J. Stirnemann, F. Caux et al., “New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes,” Rheumatology, vol. 47, no. 3, pp. 309–310, 2008.
- I. Aksentijevich, C. D. Putnam, E. F. Remmers et al., “The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model,” Arthritis and Rheumatism, vol. 56, no. 4, pp. 1273–1285, 2007.
- J. R. Yu and K. S. Leslie, “Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response,” Current Allergy and Asthma Reports, vol. 11, no. 1, pp. 12–20, 2011.
- D. Rigante, A. Leone, R. Marrocco, M. E. Laino, and A. Stabile, “Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA),” Rheumatology International, vol. 31, no. 12, pp. 1661–1664, 2011.
- H. J. Lachmann, I. Kone-Paut, J. B. Kuemmerle-Deschner et al., “Use of canakinumab in the cryopyrin-associated periodic syndrome,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2416–2425, 2009.
- D. Rigante and L. Cantarini, “Monogenic autoinflammatory syndromes at a dermatological level,” Archives of Dermatological Research, vol. 303, no. 6, pp. 375–380, 2011.
- B. Tallon and M. Corkill, “Peculiarities of PAPA syndrome,” Rheumatology, vol. 45, no. 9, pp. 1140–1143, 2006.
- A. P. Demidowich, A. F. Freeman, D. B. Kuhns et al., “Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne),” Arthritis and Rheumatism, vol. 64, no. 6, pp. 2022–2027, 2012.
- I. Aksentijevich, S. L. Masters, P. J. Ferguson, et al., “An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist,” The New England Journal of Medicine, vol. 360, pp. 2426–2437, 2009.
- E. B. Blau, “Familial granulomatous arthritis, iritis, and rash,” Journal of Pediatrics, vol. 107, no. 5, pp. 689–693, 1985.
- P. Sfriso, F. Caso, S. Tognon, P. Galozzi, A. Gava, and L. Punzi, “Blau syndrome, clinical and genetic aspects,” Autoimmunity Reviews, vol. 12, no. 1, pp. 44–51, 2012.
- N. Kanazawa, “Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy,” Allergology International, vol. 61, no. 2, pp. 197–206, 2012.
- A. Torrelo, S. Patel, I. Colmenero et al., “Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome,” Journal of the American Academy of Dermatology, vol. 62, no. 3, pp. 489–495, 2010.
- J. D. Cañete, J. I. Aróstegui, R. Queiró et al., “Association of intermittent hydrarthrosis with MEFV gene mutations,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2334–2335, 2006.
- M. Piastra, D. Pietrini, G. Conti, G. de Rosa, and D. Rigante, “Sudden shock from capillary leak,” The Lancet, vol. 379, no. 9819, p. 976, 2012.
- J. D. Cañete, J. I. Arostegui, R. Queiró et al., “An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism,” Arthritis and Rheumatism, vol. 56, no. 8, pp. 2784–2788, 2007.
- N. T. Haar, H. Lachmann, S. Ozen, et al., “Treatment of autoinflammatory diseases: results from the eurofever registry and a literature review,” Annals of the Rheumatic Diseases, vol. 72, no. 5, pp. 678–685, 2013.
- K. Migita, R. Uehara, Y. Nakamura et al., “Familial Mediterranean fever in Japan,” Medicine, vol. 91, no. 6, pp. 337–343, 2012.